Arcioni R, Palmisani S, Tigano S, Santorsola C, Sauli V, Romanò S, Mercieri M, Masciangelo R, De Blasi R A, Pinto G
Department of Anesthesia and Intensive Care Medicine, La Sapienza University of Rome, II Faculty of Medicine, S. Andrea Hospital, Rome, Italy.
Acta Anaesthesiol Scand. 2007 Apr;51(4):482-9. doi: 10.1111/j.1399-6576.2007.01263.x.
New ways of decreasing post-operative analgesic drug requirements are of special interest after major surgery. Magnesium sulfate (MgSO(4)) alters pain processing and reduces the induction and maintenance of central sensitization by blocking the N-methyl-D-aspartate (NMDA) receptor in the spinal cord. We investigated whether supplementation of spinal anesthesia with combined intrathecally and epidurally infused MgSO(4) reduced patients' post-operative analgesia requirements.
In a randomized, prospective, double-blind, placebo-controlled trial, we enrolled 120 consecutive patients undergoing orthopedic surgery during spinal anesthesia (levobupivacaine and sufentanil). Patients were randomly assigned to receive intrathecal MgSO(4) (94.5 mg, 6.3%), epidural MgSO(4) (2%, 100 mg/h), intrathecal and epidural MgSO(4) combined or spinal anesthesia alone (controls). Post-operative morphine consumption was assessed in all groups by patient-controlled analgesia (PCA).
Of the 120 patients enrolled, 103 (86%) completed the study. Morphine consumption at 36 h after surgery was 38% lower in patients receiving spinal anesthesia plus epidural MgSO(4) [- 14.963 mg; 95% confidence interval (CI), - 1.44 to - 28.49 mg], 49% lower in those receiving spinal anesthesia plus intrathecal MgSO(4) (- 18.963 mg; 95% CI, - 5.27 to - 32.65 mg) and 69% lower in the intrathecal-epidural combined group (- 26.963 mg; 95% CI, - 13.73 to - 40.19 mg) relative to control patients receiving spinal anesthesia alone. No complications developed during the post-operative course or at 1 month after surgery.
In patients undergoing orthopedic surgery, supplementation of spinal anesthesia with combined intrathecal and epidural MgSO(4) significantly reduces patients' post-operative analgesic requirements.
降低大手术后术后镇痛药物需求的新方法备受关注。硫酸镁(MgSO₄)可改变疼痛处理过程,并通过阻断脊髓中的N-甲基-D-天冬氨酸(NMDA)受体来减少中枢敏化的诱导和维持。我们研究了鞘内和硬膜外联合注入MgSO₄辅助脊髓麻醉是否能降低患者的术后镇痛需求。
在一项随机、前瞻性、双盲、安慰剂对照试验中,我们纳入了120例连续接受脊髓麻醉(左旋布比卡因和舒芬太尼)的骨科手术患者。患者被随机分配接受鞘内MgSO₄(94.5mg,6.3%)、硬膜外MgSO₄(2%,100mg/h)、鞘内和硬膜外联合MgSO₄或单纯脊髓麻醉(对照组)。所有组均通过患者自控镇痛(PCA)评估术后吗啡消耗量。
在纳入的120例患者中,103例(86%)完成了研究。与单纯接受脊髓麻醉的对照患者相比,接受脊髓麻醉加硬膜外MgSO₄的患者术后36小时的吗啡消耗量降低了38%[-14.963mg;95%置信区间(CI),-1.44至-28.49mg],接受脊髓麻醉加鞘内MgSO₄的患者降低了49%(-18.963mg;95%CI,-5.27至-32.65mg),鞘内-硬膜外联合组降低了69%(-26.963mg;95%CI,-13.73至-40.19mg)。术后过程中或术后1个月均未出现并发症。
在接受骨科手术的患者中,鞘内和硬膜外联合MgSO₄辅助脊髓麻醉可显著降低患者的术后镇痛需求。